Clinical Trial Update: A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing valsartan alone to valsartan plus hydrochlorothiazide in adults with hypertension has completed. The sponsor was Novartis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED